Genprex, Inc. (@genprex) header
Genprex, Inc. (@genprex) profile picture

Genprex, Inc.

@genprex

Genprex (Nasdaq: $GNPX) is a clinical-stage gene therapy company focused on developing life-changing technologies for patients with cancer and diabetes.

 Austin, TX
genprex.com
Joined July 2016
  • Tweets1.3K
  • Following501
  • Followers2.4K
897Media
Photo by Genprex, Inc. (@genprex)Photo by Genprex, Inc. (@genprex)Photo by Genprex, Inc. (@genprex)Photo by Genprex, Inc. (@genprex)Photo by Genprex, Inc. (@genprex)Photo by Genprex, Inc. (@genprex)Photo by Genprex, Inc. (@genprex)Photo by Genprex, Inc. (@genprex)Photo by Genprex, Inc. (@genprex)Photo by Genprex, Inc. (@genprex)
$GNPX CEO recently sat down with the Beyond Biotech Podcast to highlight our diabetes gene therapy and its potential within the therapeutic landscape. Learn more about how we're aiming to address the unmet medical needs of #diabeticpatients Listen here: ow.ly/Yf5m51034J9
Genprex bets on a one-time gene therapy for diabetes (Part 3 of 3) -...

Genprex bets on a one-time gene therapy for diabetes (Part 3 of 3) -...

Welcome to a special three-part series called 'The Metabolic Moment'.In just a few years, GLP-1 drugs have become a phenomenon. They’ve transformed how we treat diabetes and obesity, created one of...

podcast.labiotech.eu
143
Genprex Highlights New Preclinical Data Identifying Role of TUSC2, the Gene Used in REQORSA®, in Maintaining Cellular Function During Brain Aging: ow.ly/KBsY50ZZGQ3 #Aging
Image from Genprex, Inc. (@genprex)
2
510
Genprex to Present at the H.C. Wainwright 28th Annual Global Investment Conference: ow.ly/iM7q50ZKCLi #GeneTherapy #LungCancer #Diabetes
Image from Genprex, Inc. (@genprex)
1
3
223
$GNPX has treated 100+ patients with Reqorsa® throughout its various clinical trials. While other cancer treatments can cause harsh side effects and have long-term effects, we believe in REQORSA’s high degree of patient safety and tolerability #LungCancer
1
3
275
Genprex Selects Leading Clinical and Commercial Contract Development and Manufacturing Organization for Manufacturing Scale Up of Diabetes Gene Therapy: ow.ly/X8cq50ZATey #Diabetes #GeneTherapy
Image from Genprex, Inc. (@genprex)
3
298
Genprex Announces Collaboration with Roche Diagnostics for Biomarker Assay Validation Studies: ow.ly/YY5m50ZvMn7 #LungCancer
Image from Genprex, Inc. (@genprex)
2
8
621
Genprex Receives a Notice of Allowance from The Canadian Intellectual Property Office for a Patent Claiming the Combination of Reqorsa® Gene Therapy with Either PD-1 or PD-L1 Antibodies to Treat Cancer: ow.ly/9Bj150ZfcY9 #LungCancer #GeneTherapy
Image from Genprex, Inc. (@genprex)
1
1
1
285
Genprex to Participate at BIO International Convention 2026: ow.ly/WLjg50ZcIk6 #BIO2026 #GeneTherapy #LungCancer #Diabetes
Image from Genprex, Inc. (@genprex)
1
111
A few members from the Genprex team attended #ASCO2026 this week where our collaborators' abstract was published detailing positive clinical data from studies of predictive biomarkers in patients receiving Reqorsa® for the treatment of #lungcancer.
Image from Genprex, Inc. (@genprex)
3
223
Positive Clinical Data on Biomarkers in Patients Receiving Reqorsa® Gene Therapy Published at the 2026 ASCO Annual Meeting: ow.ly/mlEW50Z4bQs #ASCO #LungCancer
Image from Genprex, Inc. (@genprex)
4
175
Our research collaborators presented positive preclinical data on our diabetes gene therapy at the 2026 ASGCT Annual Meeting. The poster can be reviewed in detail by clicking here: ow.ly/5to850Z0ee2 #Diabetes #Type2 #GeneTherapy
Image from Genprex, Inc. (@genprex)
4
167
Genprex Collaborators Present Positive Preclinical Data on Diabetes Gene Therapy for Type 2 Diabetes at the 2026 American Society of Gene and Cell Therapy Annual Meeting: ow.ly/uQlx50YZtGn #GeneTherapy #Diabetes
Image from Genprex, Inc. (@genprex)
3
223
Genprex was featured in Cure's Member Spotlight series, where they highlight the groundbreaking work of the companies and individuals in Cure’s community. Check out the Q&A with Genprex's President and CEO here: ow.ly/ByIR50YZ0Ns #GeneTherapy #LungCancer #Diabetes
Cure Member Spotlight: Ryan Confer

Cure Member Spotlight: Ryan Confer

A Q&A with CEO of Genprex on the intravenous gene therapy platform behind Reqorsa, how the company is advancing pipelines in both lung cancer and diabetes, and what it still needs to prove.

wewillcure.com
1
3
5
283
Genprex Receives Patent Grant from The Israel Patent Office for the Combination of Reqorsa® Gene Therapy and PD-1 Antibodies to Treat Cancer: ow.ly/irx250YSoy9 #GeneTherapy #LungCancer
Image from Genprex, Inc. (@genprex)
1
4
315
Genprex Collaborators to Present Positive Preclinical Data on Diabetes Gene Therapy for Type 2 Diabetes at the 2026 American Society of Gene and Cell Therapy Annual Meeting: ow.ly/hizI50YR0Ly #Diabetes #GeneTherapy
Image from Genprex, Inc. (@genprex)
1
5
269
Genprex collaborators presented preclinical data at #AACR26 in a poster, titled, "Restoring TUSC2 function boosts NK cell cytotoxicity and antitumor immunity in vivo and in vitro." To view the poster, click here: ow.ly/cPHL50YNAi3 #GeneTherapy $GNPX
Image from Genprex, Inc. (@genprex)
5
4
339
$GNPX Collaborators presented preclinical data on Reqorsa Gene Therapy in EML4-ALK bearing NSCLC at #AARC26. Read the poster in more detail here: ow.ly/fIJb50YNAbS #LungCancer #GeneTherapy
Image from Genprex, Inc. (@genprex)
5
262
$GNPX's Chief Medical Officer, Mark Berger, MD, poses with one of our collaborators at the #AACR26 conference. To view the poster, "TROP2 and PTEN Biomarkers May Predict Patient Response to Reqorsa® Gene Therapy" in more detail, click here: ow.ly/Z1ol50YNA2l #LungCancer
Image from Genprex, Inc. (@genprex)
1
7
360
Positive Clinical Data on Biomarkers in Patients Receiving Reqorsa® Gene Therapy To Be Released at the 2026 ASCO Annual Meeting: ow.ly/eQgk50YNUgU #LungCancer #GeneTherapy
Image from Genprex, Inc. (@genprex)
2
3
271
Genprex Signs Sponsored Research Agreement to Study Biomarkers that May Predict Patient Response to Reqorsa® Gene Therapy: genprex.com/2026/04/21/genpr… #lungcancer #tailoredtreatment #genetherapy
Image from Genprex, Inc. (@genprex)
2
4
178
Load more